Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open ‐label, long‐term safety and efficacy study
This study aimed to investigate zoledronic acid treatment on postmenopausal osteoporosis in Uighur and Han patients in Xinjiang province, China. MethodsA self‐controlled and prospective trial design was adopted. A total of 155 Uighur and 151 Han patients were enrolled. All subjects received an intravenous infusion of zoledronic acid (5 mg) at day 0 (baseline) and at 12 months. Patients were followed up for 24 months; the bone mineral density (BMD) of the left total hip and L1–L4 vertebrae was measured at day 0 and at 24 months. Results and discussionBMD was significantly higher after zoledronic acid treatment compa...
Source: Journal of Clinical Pharmacy and Therapeutics - November 7, 2017 Category: Drugs & Pharmacology Authors: W. Xu, C. Xiang, H. Wang, H. Yuan, X. Zhao, X. Xiao Tags: ORIGINAL ARTICLE Source Type: research

Brand vs generic adverse event reporting patterns: An authorized generic ‐controlled evaluation of cardiovascular medications
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 3, Page 327-335, June 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 1, 2017 Category: Drugs & Pharmacology Authors: Y. Alatawi PharmD , Md. M. Rahman MPharm , N. Cheng MS , J. Qian PhD , P. L. Peissig PhD, MBA , R. L. Berg MS , C. D. Page PhD , R. A. Hansen PhD Source Type: research

Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 3, Page 320-326, June 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 1, 2017 Category: Drugs & Pharmacology Authors: H. Capelle PharmD , C. Tummino MD , L. Greillier MD, PhD , M. Gouitaa MD , J. Birnbaum MD , N. Ausias PharmD , F. Barlesi MD, PhD , M. Montana PharmD, PhD Source Type: research

Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service
Journal of Clinical Pharmacy and Therapeutics, EarlyView. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 1, 2017 Category: Drugs & Pharmacology Source Type: research

Brand vs generic adverse event reporting patterns: An authorized generic ‐controlled evaluation of cardiovascular medications
Journal of Clinical Pharmacy and Therapeutics, EarlyView. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 1, 2017 Category: Drugs & Pharmacology Source Type: research

---
Journal of Clinical Pharmacy and Therapeutics, Ahead of Print. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 1, 2017 Category: Drugs & Pharmacology Source Type: research

Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service
Summary What is known and objectiveWith the increasing use of cancer chemotherapy agents, hypersensitivity reactions are commonly encountered. The allergic clinical symptoms are variable and unpredictable. The aim of this study was to identify the characteristics of hypersensitivity reactions and to assess the value of skin tests for platinum salts and pemetrexed in the treatment of patients with non‐small cell lung cancers or malignant pleural mesothelioma. MethodsA single‐centre retrospective study was performed for 2 years. Patients treated with the drugs of interest for an advanced or metastatic non‐small cell l...
Source: Journal of Clinical Pharmacy and Therapeutics - November 1, 2017 Category: Drugs & Pharmacology Authors: H. Capelle, C. Tummino, L. Greillier, M. Gouitaa, J. Birnbaum, N. Ausias, F. Barlesi, M. Montana Tags: ORIGINAL ARTICLE Source Type: research

Rapid onset of conjunctivitis associated with overdosing of erlotinib
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 296-298, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - October 25, 2017 Category: Drugs & Pharmacology Source Type: research

---
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 296-298, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - October 25, 2017 Category: Drugs & Pharmacology Source Type: research

PFA ‐100‐measured aspirin resistance is the predominant risk factor for hospitalized cardiovascular events in aspirin‐treated patients: A 5‐year cohort study
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 249-255, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - October 21, 2017 Category: Drugs & Pharmacology Source Type: research

---
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 249-255, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - October 21, 2017 Category: Drugs & Pharmacology Source Type: research

Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 220-223, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - October 13, 2017 Category: Drugs & Pharmacology Source Type: research

Evaluation of the predictive performance of bleeding risk scores in patients with non ‐valvular atrial fibrillation on oral anticoagulants
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 209-219, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - October 13, 2017 Category: Drugs & Pharmacology Source Type: research

---
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 220-223, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - October 13, 2017 Category: Drugs & Pharmacology Source Type: research